Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference
May 29, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, May 29, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month
May 26, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, May 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that its...
Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
May 20, 2020 16:20 ET
|
Meridian Bioscience Inc.
CINCINNATI, May 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc.’s (NASDAQ: VIVO) Board of Directors announced that Tony Serafini-Lamanna has been promoted to Executive Vice President of...
Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products
May 08, 2020 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020...
Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay
May 06, 2020 08:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, May 06, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its...
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience
April 30, 2020 10:50 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 30, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously...
Meridian Bioscience Simplifies COVID-19 Sample Prep and Eliminates Dependence on Reagents in Short Supply
April 27, 2020 11:56 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that...
Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020
April 16, 2020 09:00 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report second quarter 2020...
Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests
April 14, 2020 09:33 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody...
MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH
April 02, 2020 07:30 ET
|
Meridian Bioscience Inc.
CINCINNATI, April 02, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update...